Blog Post

Introduction: The No-Choice Illusion You’ve seen it, and we know it: The pharma industry’s two-organization monopoly of IRB services promises devotion to your clinical trials…

Overview In stressful situations, it’s human nature to react instinctively rather than respond logically—to run towards or away from a developing emergency. Yet, laboratories throughout…

From the CRO perspective, navigating the IBC process for the first time can feel daunting. And even experienced personnel will sometimes shudder at past IBC…

Sabai IRB Chair Stephanie Solomon Cargill attended a series of FDA engagement sessions, gathering valuable insights on how the latest guidance accords with the concerns, interests…